AI News
NVIDIA BioNeMo Toolkit Targets Reliable AI Drug Discovery
NVIDIA launches BioNeMo agent toolkit to solve AI reliability issues in drug discovery and genomics, targeting the $300B life sciences R&D market.
NVIDIA launches BioNeMo agent toolkit to solve AI reliability issues in drug discovery and genomics, targeting the $300B life sciences R&D market.